ZATTARIN, EMMA
 Distribuzione geografica
Continente #
EU - Europa 38
NA - Nord America 33
AS - Asia 13
OC - Oceania 4
AF - Africa 2
Totale 90
Nazione #
US - Stati Uniti d'America 32
IT - Italia 26
IQ - Iraq 6
AU - Australia 4
GB - Regno Unito 3
FR - Francia 2
ID - Indonesia 2
IE - Irlanda 2
IR - Iran 2
JP - Giappone 2
MA - Marocco 2
CA - Canada 1
DE - Germania 1
DK - Danimarca 1
ES - Italia 1
NL - Olanda 1
PH - Filippine 1
SE - Svezia 1
Totale 90
Città #
Rho 10
Erbil 6
Ashburn 5
Fleming Island 4
Hay Point 3
London 3
Milan 3
Avezzano 2
Bibiana 2
Boardman 2
Dublin 2
Kenitra 2
Atlanta 1
Bellevue 1
Brooklyn 1
Chicago 1
Dallas 1
Drexel Hill 1
Holbaek 1
Kofu 1
Kure 1
Montgomery 1
Montreal 1
Murcia 1
Naples 1
New York 1
Omaha 1
Reston 1
San Diego 1
Santa Clara 1
Santa Cruz 1
Seattle 1
Stockholm 1
Sydney 1
Wilmington 1
Totale 67
Nome #
Hormone Receptor Loss in Breast Cancer: Molecular Mechanisms, Clinical Settings, and Therapeutic Implications, file 9925aec8-6b35-42ec-ba83-700fe8d975a5 30
The pan-immune-inflammation-value predicts the survival of patients with human epidermal growth factor receptor 2 (Her2)—positive advanced breast cancer treated with first-line taxane-trastuzumab-pertuzumab, file dfa8b9a9-b059-748b-e053-3a05fe0a3a96 12
Evaluation of drug-drug interactions in EGFR-mutated non-small-cell lung cancer patients during treatment with tyrosine-kinase inhibitors, file dfa8b9a9-b54b-748b-e053-3a05fe0a3a96 12
Machine Learning Using Real-World and Translational Data to Improve Treatment Selection for NSCLC Patients Treated with Immunotherapy, file dfa8b9a9-bcae-748b-e053-3a05fe0a3a96 9
Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world scenario, file 09b0c2ea-bfa5-4872-9c2c-04efccf398b6 8
Hormone receptor status influences the impact of body mass index and hyperglycemia on the risk of tumor relapse in early-stage HER2-positive breast cancer patients, file dfa8b9a9-8059-748b-e053-3a05fe0a3a96 5
Immune-Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer With Uncommon Histology, file dfa8b9a9-871b-748b-e053-3a05fe0a3a96 3
Prolonged benefit from palbociclib plus letrozole in heavily pretreated advanced male breast cancer: case report, file dfa8b9a9-9847-748b-e053-3a05fe0a3a96 3
Targeting lipid metabolism is an emerging strategy to enhance the efficacy of anti-HER2 therapies in HER2-positive breast cancer, file dfa8b9a9-d4d9-748b-e053-3a05fe0a3a96 3
Cabozantinib beyond progression improves survival in advanced renal cell carcinoma patients: the CABEYOND study (Meet-URO 21), file dfa8b9a9-ad56-748b-e053-3a05fe0a3a96 2
Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world scenario, file 39013078-dd90-40a7-9b9c-069794d44d30 1
Monitoring patients with head and neck cancer for flu-like symptoms during the COVID-19 pandemic, file dfa8b9a6-a600-748b-e053-3a05fe0a3a96 1
Case Report: Prolonged clinical benefit with sequential trastuzumab-containing treatments in a patient with advanced extramammary Paget disease of the groin, file e44ab2a8-aad2-4311-bde7-0a6ad4f36ffa 1
Totale 90
Categoria #
all - tutte 227
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 227


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211 0000 00 00 0010
2021/202220 0000 00 07 0049
2022/202369 2041 35 1116 76131
Totale 90